Condition

Schizophrenia Disorders

ClinicalTrials.gov condition label

Clinical trials40
Recruiting24
Common interventions25
Lead sponsors shown15

Clinical trials

40 shown
Cognitive Remediation Method Using Rhythmic, Vocal and Corporal Musical Learning for SchizophreniaNCT07055204 · 2026-09-04
RECRUITING
Transition Care for FEPNCT07713849 · 2026-05-06
RECRUITING
Epigenetic Enhancement of Cognitive Training in Aging Mood and Schizophrenia Spectrum Disorder PopulationsNCT07404085 · 2025-11-14
RECRUITING
Visual Perception in SchizophreniaNCT06911931 · 2025-11-03
RECRUITING
Brain Stimulation to the Hippocampus in SchizophreniaNCT07010614 · 2025-10-01
RECRUITING
Randomized Clinical Trial of iTEST: A Blended Intervention Targeting Introspective AccuracyNCT07098169 · 2025-09-01
RECRUITING
Activities to Change Your Mood: A Test of the Acceptability and Initial Efficacy in Clinical Samples and Healthy ControlsNCT06911723 · 2025-08-20
RECRUITING
SEEG-Guided DBS for SchizophreniaNCT07671261 · 2025-08-17
RECRUITING
Creating a Global Research Database That Connects Genetic Information and Long-term Health Data to Improve Personalized Treatment for People With Serious Mental IllnessNCT06641726 · 2025-05-16
RECRUITING
Effects of Tirzepatide on Alcohol Intake in Patients Diagnosed With Schizophrenia and Alcohol Use DisorderNCT06939088 · 2025-05-05
RECRUITING
Cognitive Remediation Therapy for Schizophrenia: Effects on EEG and Emotional RegulationNCT06936397 · 2025-03-15
RECRUITING
40 Hz Visual Stimulation as an Intervention in SchizophreniaNCT06907420 · 2025-03-14
RECRUITING
The Effect of Mindfulness-Based Psychoeducation Programme Given Individually to Schizophrenia Patients on Internalised Stigma and Healthy Lifestyle BehavioursNCT06882538 · 2025-02-14
RECRUITING
Volatility in Paranoia (VIP) Trial: An RCT of Changes in Volatility With PsychotherapyNCT06835556 · 2025-01-15
RECRUITING
Investigating the Effect of Diroximel Fumarate on Glutathione in SchizophreniaNCT06957808 · 2025-01-10
RECRUITING
White Matter Plasticity in SchizophreniaNCT06641297 · 2025-01-02
RECRUITING
Asylumseekers Experiencing Paranoid Delusions: A Virtual Reality StudyNCT06692530 · 2024-11-22
RECRUITING
Development and Application of Precision Treatment Strategies for Common Mental DisordersNCT06729541 · 2024-11-11
RECRUITING
The Key to Integrated Trauma Treatment in Psychosis TrialNCT06608706 · 2024-09-01
RECRUITING
The Purpose of This Study is to Determine the Safety, Tolerability, and Pharmacokinetics of Brexpiprazole Long-acting Injection Following a Single Administration in Healthy Subjects/Patients With Schizophrenia.NCT06674694 · 2024-04-10
RECRUITING
An Integrated Neurophysiological Approach Toward the Early Detection of Psychiatric DisordersNCT06886945 · 2024-04-09
RECRUITING
Medical Phenotyping of NHS General Adult Psychiatry (GAP) InpatientsNCT07398365 · 2024-04-03
RECRUITING
Cognitive and Metacognitive Evaluation in VR-Based Avatar Therapy for PsychosisNCT07091344 · 2024-03-01
RECRUITING
HYEEG Discourse in Psychosis: A Neurobehavioural StudyNCT06978803 · 2024-01-16
RECRUITING
Non-Coding RNAs Gene Expression in Psychiatric DisordersNCT07649993 · 2026-09-01
NOT_YET_RECRUITING
Arts-based Social Prescribing for Mental HealthNCT07137572 · 2025-09-04
COMPLETED
Recovery in Telling Life StoriesNCT07082777 · 2025-07-21
ACTIVE_NOT_RECRUITING
Investigation of the Effects of Virtual Reality Applications on Individuals Diagnosed With SchizophreniaNCT07027085 · 2025-06-02
ACTIVE_NOT_RECRUITING
Psychiatric Disorders in Child and Adolescent Offspring of Parents with Schizophrenia and Bipolar Disorders.NCT06874075 · 2025-05-20
NOT_YET_RECRUITING
DIALOG: Understanding Disorganisation: A Language-focused Global Initiative in PsychosisNCT06978465 · 2025-05-19
NOT_YET_RECRUITING
An 8-week Open-label Study of an Accelerated and Slower Switching to Xanomeline/Trospium Following Atypical Antipsychotic Treatment in Participants With SchizophreniaNCT06924255 · 2025-04-01
NOT_YET_RECRUITING
MonPsy&Moi: A Digital Platform for Collecting Patient-Reported Experience and Outcome Measures in PsychiatryNCT06818227 · 2025-02-02
NOT_YET_RECRUITING
Effect of Melatonin on Schizophrenic Symptoms: a Randomized Placebo-Controlled TrialNCT06838104 · 2024-12-05
ACTIVE_NOT_RECRUITING
Magnetoencephalography in Psychosis ProgramNCT06978881 · 2024-05-08
ENROLLING_BY_INVITATION
Culturally Adapted Cognitive Behavior Therapy Based Guided Self-help Manual for Schizophrenia Spectrum DisorderNCT06895421 · 2023-10-16
COMPLETED
The Effects of Mindfulness and Web-Based Physical Activity Program in Patients With SchizophreniaNCT06886607 · 2023-10-16
COMPLETED
Occurrence and Influencing Factors of Cognitive Impairment in Elderly Patients With Schizophrenia andNCT06949657 · 2023-10-13
TERMINATED
Efficacy & Tolerability of Rigth Unilateral vs. Bitemporal ECT in Schizophrenia in a Psychiatric Hospital in MexicoNCT06972745 · 2023-03-16
TERMINATED
Effect of AQW051 on Cognitive Function in Patients With Chronic Stable SchizophreniaNCT01163227 · 2010-05-01
COMPLETED
Evaluating a Collaborative Care Model for the Treatment of Schizophrenia (EQUIP)NCT00119574 · 2002-01-01
COMPLETED

Common interventions

PlaceboDRUG3"Diapason & Metronome" musical learningOTHER1Active ControlBEHAVIORAL1AQW051 100mg (single dose), and 50mg (multiple doses)DRUG1AQW051 15mg (single and multiple doses)DRUG1AQW051 2 mg (single and multiple doses)DRUG1Art PrescriptionOTHER1Audio-Visual Perceptual TasksOTHER1awareness-based psychoeducationOTHER1Brexpiprazole long-acting injectionDRUG1Brief ActivitiesBEHAVIORAL1Brief pulse Electroconvulsive therapyPROCEDURE1Cognitive behavior therapy based guided self help manual for psychosis plus treatment as usualBEHAVIORAL1Cognitive Behavioral TherapyBEHAVIORAL1Cognitive Remediation TherapyBEHAVIORAL1Collaborative Chronic Illness ModelPROCEDURE1Deep brain stimulationDEVICE1Diroximel fumarate (DRF)DRUG1EEG measure of visual processingOTHER1Eye Movement Desensitization and Reprocessing (EMDR) for psychosisOTHER1HDACi butyrateDIETARY_SUPPLEMENT1Intracranial electrodesDEVICE1iTESTBEHAVIORAL1MelatoninDRUG1Multigenetic Pharmacogenomics-Guided Treatment (MPGT)OTHER1

Trial status mix

RECRUITING24
COMPLETED5
NOT_YET_RECRUITING5
ACTIVE_NOT_RECRUITING3
TERMINATED2
ENROLLING_BY_INVITATION1

Phase mix

NA25
PHASE22
PHASE11
PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.